Research Funded To Date
The Ben and Catherine Ivy Foundation is dedicated to finding a cure for brain cancer. We strive in improve the quality of life and increase the life expectancy of those diagnosed with brain cancer by funding promising research that creates more diagnostics and treatments for patients.
Since 2008, we have funded 40 separate institutions with over 120 different research grants totaling over $174 million. These grants have involved research in phase 0 clinical trials, biomarkers, genomics, imaging, immunotherapy, stem cell, vaccines, and the development of possible new drugs.
2025
MEASURING AND INHIBITING SERINE METABOLISM IN IDH MUTANT GLIOMAS
PI: Daniel R. Wahl, MD, PhD
Associate Professor of Radiation Oncology
Regents of the University of Michigan
Wajd Al-Holou, MD
Assistant Professor of Neurosurgery
Regents of the University of Michigan
PATIENT REFINED ENROLLMENT TO GLIOBLASTOMA UMBRELLA SIGNATURE TRIAL (PRE-GUST)
PI: Michael Berens, PhD
Professor
The Translational Genomics Research Institute (TGen)
Kamel Lahouel, PhD
Assistant Professor
The Translational Genomics Research Institute (TGen)
ENHANCING EGFR INHIBITOR EFFICACY IN GLIOBLASTOMA
PI: Shwetal Mehta, PhD
Professor and Deputy Director
Ivy Brain Tumor Center, Barrow Neurological Institute
An-Chi, Tein, PhD
Assistant Professor
Ivy Brain Tumor Center, Barrow Neurological Institute
PRECISION RADIOTHERAPY OF GLIOBLASTOMA ENABLED BY AMIDE PROTON TRANSFER MRI
PI: Jinyuan Zhou, PhD
Professor of Radiology and Oncology
Johns Hopkins University
Kristin Janson Redmond, MD
Associate Professor
Johns Hopkins University
TACKLING GLIOBLASTOMAS DRIVEN BY GENOMIC HAPLOIDIZATION
PI: David A. Solomon, MD, PhD
Director of Neuropathology and Associate Professor
Stanford Brain Tumor Center
A NOVEL THERAPEUTIC STRATEGY AND COMPANION DIAGNOSTIC TO TARGET GLUTAMATERGIC SIGNALING IN GLIOBLASTOMA
PI: Corinne Beinat, PhD
Assistant Professor of Radiology
Stanford University
Thomas Jude Montine, MD, PhD
Chair, Department of Pathology
Stanford University
EVALUATION OF REDOX‐BASED COMBINATORIAL STRATEGIES FOR GLIOBLASTOMA THERAPY
PI: Artak Tovmasyan, PhD
Associate Professor, Research
Ivy Brain Tumor Center, Barrow Neurological Institute
ABLATING 1D01 FOR IMPROVING IMMUNOTHERAPEUTIC EFFICACY AGAINST GLIOBLASTOMA
PI: Derek A. Wainwright, PhD
Associate Professor (Tenured), Departments of Cancer Biology and Neurological Surgery
Loyola University Chicago Strich School of Medicine
Gary E. Schittz, PhD
Medicinal Chemist
Northwestern University
Rimas Lukas, MD
Associate Professor, Neuro-Oncologists
Northwestern University
Qunfeng Dong, PhD
Professor, Computational Biologists & Biostatistician
Loyola University
NEUROLOGICAL SCIENCES INTERNSHIP PROGRAM AT TGEN DESIGNED TO GIVE HIGH SCHOOL AND UNDERGRADUATE STUDENTS INTENSIVE, HANDS-ON RESEARCH EXPERIENCE WORKING ALONGSIDE A MENTOR-SCIENTIST TO LEARN ABOUT TRANSLATIONAL RESEARCH WHILE INVESTIGATING QIESTIONS WITHIN THE NEUROLOGICAL SCIENCES
PI: Kristen Kaus
Manager of Education and Outreach
Translational Genomics Research Institute (TGEN)